# Oruka Therapeutics, Inc.: Form SC 13D, filed Apr 5, 2024

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: SC 13D
- Filed: 2024-04-05
- Accepted by EDGAR: Apr 5, 2024, 16:05 ET
- Period: not reported
- Accession: 0000902664-24-002769
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000090266424002769/p24-1381sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000090266424002769/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000090266424002769/p24-1381sc13d.htm

Filed Apr 5, 2024.
Source: SEC EDGAR, the filing index for accession 0000902664-24-002769. Last ingested by Listed: Oct 26, 2026, 08:01 ET. No prices; not investment advice.